TME PHARMA ANNOUNCES THE INITIATION OF THE LISTING OF PREFERENTIAL SUBSCRIPTION RIGHTS FOR FULLY GUARANTEED €2.7 MILLION CAPITAL INCREASE
- Guaranteed portion of the transaction will extend cash runway past
regulatory milestones in Q1-2024
- The financial visibility will allow TME Pharma to file and receive
feedback from FDA on its IND and applications to expedited regulatory …